Free Trial

Verici Dx (VRCI) Competitors

Verici Dx logo
GBX 1.20 -0.05 (-4.00%)
As of 10:26 AM Eastern

VRCI vs. ABDX, PRM, GDR, GENI, DMTR, LLAI, LLA, IDHC, DXRX, and AGL

Should you be buying Verici Dx stock or one of its competitors? The main competitors of Verici Dx include Abingdon Health (ABDX), Proteome Sciences (PRM), genedrive (GDR), GENinCode (GENI), Deepmatter Group (DMTR), LungLife AI (LLAI), LLA.L,0P0001T9GN,0 (LLA), Integrated Diagnostics (IDHC), Diaceutics (DXRX), and ANGLE (AGL). These companies are all part of the "diagnostics & research" industry.

Verici Dx vs.

Verici Dx (LON:VRCI) and Abingdon Health (LON:ABDX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, media sentiment, risk, community ranking and dividends.

51.9% of Verici Dx shares are held by institutional investors. Comparatively, 33.5% of Abingdon Health shares are held by institutional investors. 17.1% of Verici Dx shares are held by insiders. Comparatively, 48.9% of Abingdon Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Verici Dx has a beta of 1.59, meaning that its stock price is 59% more volatile than the S&P 500. Comparatively, Abingdon Health has a beta of 0.13, meaning that its stock price is 87% less volatile than the S&P 500.

Abingdon Health has lower revenue, but higher earnings than Verici Dx. Abingdon Health is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Verici Dx£5.91M0.62-£6.56M-£1.73-0.70
Abingdon Health£3.84M3.09-£796.37K-£0.41-14.94

Verici Dx and Abingdon Health both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Verici DxN/AN/A
Abingdon HealthN/AN/A

Abingdon Health has a net margin of -20.72% compared to Verici Dx's net margin of -110.99%. Abingdon Health's return on equity of -62.56% beat Verici Dx's return on equity.

Company Net Margins Return on Equity Return on Assets
Verici Dx-110.99% -71.67% -26.14%
Abingdon Health -20.72%-62.56%-17.93%

In the previous week, Verici Dx's average media sentiment score of 0.00 equaled Abingdon Health'saverage media sentiment score.

Company Overall Sentiment
Verici Dx Neutral
Abingdon Health Neutral

Summary

Abingdon Health beats Verici Dx on 7 of the 11 factors compared between the two stocks.

Get Verici Dx News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRCI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

VRCI vs. The Competition

MetricVerici DxDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£3.64M£786.60M£5.33B£2.62B
Dividend YieldN/A5.44%5.21%5.05%
P/E Ratio-0.702.0826.71129.34
Price / Sales0.62543.73386.13221,585.85
Price / Cash1.3111.4238.2528.03
Price / Book0.272.516.773.79
Net Income-£6.56M£286.34B£3.23B£5.88B
7 Day Performance-4.00%5.02%1.80%0.62%
1 Month Performance-40.00%2.57%11.10%22.12%
1 Year Performance-85.00%-10.28%17.11%120.96%

Verici Dx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VRCI
Verici Dx
N/AGBX 1.20
-4.0%
N/A-85.1%£3.64M£5.91M-0.7019Gap Down
ABDX
Abingdon Health
N/AGBX 6
-1.6%
N/A-42.9%£11.62M£3.84M-14.5984Gap Down
PRM
Proteome Sciences
N/AGBX 3.90
+19.6%
N/A-2.2%£11.51M£10.88B-2.82240Gap Up
High Trading Volume
GDR
genedrive
N/AGBX 1.36
-0.7%
N/A-18.7%£7.69M£1.50M-0.3843High Trading Volume
GENI
GENinCode
N/AGBX 1.50
-6.3%
N/A-80.9%£2.66M£2.67M-0.442,300News Coverage
Gap Up
High Trading Volume
DMTR
Deepmatter Group
N/AN/AN/AN/A£1.33M£1.04M-0.11N/AGap Down
LLAI
LungLife AI
N/AGBX 3.75
+7.1%
N/A-82.9%£1.24M£33,871.03-0.3015Gap Down
LLA
LLA.L,0P0001T9GN,0
N/AN/AN/AN/A£0.00N/A-8.3315Gap Down
High Trading Volume
IDHC
Integrated Diagnostics
N/AGBX 0.36
+2.9%
N/A+14.3%£10.60B£23.29T13.386,692
DXRX
Diaceutics
1.5748 of 5 stars
GBX 130
-0.8%
GBX 160
+23.1%
+13.9%£109.71M£26.08M-38.56151News Coverage
Gap Down
High Trading Volume
AGL
ANGLE
1.2615 of 5 stars
GBX 8
-6.3%
GBX 40
+400.0%
-53.7%£25.78M£2.44M-1.18650

Related Companies and Tools


This page (LON:VRCI) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners